<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="77377">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02089945</url>
  </required_header>
  <id_info>
    <org_study_id>503-2013</org_study_id>
    <nct_id>NCT02089945</nct_id>
  </id_info>
  <brief_title>Pilot Study of Cognitive and Functional Outcomes Following TAVI</brief_title>
  <official_title>Cognitive and Functional Outcomes Following Transcatheter Aortic Valve Implantation (TAVI): a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sunnybrook Health Sciences Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sunnybrook Health Sciences Centre</source>
  <oversight_info>
    <authority>Canada: Ethics Review Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Narrowing of the aortic valve in the heart, known as severe aortic stenosis, can impede
      blood delivery and is associated with poor quality of life and death. In the elderly with
      considerable medical burden, a relatively new non-invasive valve replacement technique
      called Transcatheter Aortic Valve Implantation (TAVI) can be used instead of open-heart
      surgery. However, long term changes in cognition after TAVI remain unclear and previous
      studies have suggested an increased risk of cognitive decline in patients following the
      surgical procedure. In this pilot study, the investigators will characterize changes in
      cognition, physical capacity, overall quality of life and neuropsychiatric symptoms
      (depression and apathy) over 6 months after TAVI.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">January 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Cognitive performance</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The 30-minute neuropsychiatric assessment battery recommended by NINDS-CSN (National Institute of Neurological Disorders and Stroke- Canadian Stroke Network) harmonized standards</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional capacity</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The Timed Up and Go Test (TUG) and Hand Grip Strength Test</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Quality of life</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The Minnesota Living with Heart Failure Questionnaire (MLHFQ) and EQ-5D-5L questionnaires</description>
  </other_outcome>
  <other_outcome>
    <measure>Depression</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Centre for Epidemiologic Studies Depression Scale (CES-D)</description>
  </other_outcome>
  <other_outcome>
    <measure>Apathy</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Apathy Evaluation Scale (AES)</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">31</enrollment>
  <condition>Aortic Stenosis</condition>
  <arm_group>
    <arm_group_label>transcatheter aortic valve implantation</arm_group_label>
    <description>This study recruits individuals that are undergoing transcatheter aortic valve implantation.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with a diagnosis of severe symptomatic aortic stenosis (aortic valve area &lt; 1
        cm2, mean gradient across the aortic valve of 40 mm Hg or more and a peak aortic jet
        velocity of 4.0 m/s or more) undergoing transcatheter aortic valve implantation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of severe symptomatic aortic stenosis

          -  undergoing TAVI

          -  speak and understand English

        Exclusion Criteria:

          -  emergency TAVI

          -  any medical conditions that will affect their ability to complete the protocol
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Krista L Lanctot, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sunnybrook Health Sciences Centre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Krista L Lanctot, PhD</last_name>
      <phone>4164806100</phone>
      <phone_ext>2241</phone_ext>
      <email>krista.lanctot@sunnybrook.ca</email>
    </contact>
    <investigator>
      <last_name>Krista L Lanctot, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 26, 2014</lastchanged_date>
  <firstreceived_date>March 14, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>transcatheter aortic valve implantation</keyword>
  <keyword>severe aortic stenosis</keyword>
  <keyword>cognition</keyword>
  <keyword>functional capacity</keyword>
  <keyword>quality of life</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
